Class information for:
Level 1: BASILIXIMAB//THYMOGLOBULIN//DACLIZUMAB

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
9072 1124 27.2 83%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
126 23061 TRANSPLANTATION//TRANSPLANTATION PROCEEDINGS//MYCOPHENOLIC ACID

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 BASILIXIMAB Author keyword 44 47% 6% 69
2 THYMOGLOBULIN Author keyword 36 47% 5% 56
3 DACLIZUMAB Author keyword 19 32% 4% 49
4 ALEMTUZUMAB Author keyword 13 14% 7% 82
5 CAMPATH 1H Author keyword 12 29% 3% 36
6 ANTI THYMOCYTE GLOBULIN Author keyword 10 16% 5% 56
7 INDUCTION THERAPY Author keyword 8 16% 4% 50
8 RABBIT ANTITHYMOCYTE GLOBULIN Author keyword 8 45% 1% 14
9 SIMULECT Author keyword 7 67% 1% 6
10 ANTI IL 2 RECEPTOR Author keyword 6 80% 0% 4

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 BASILIXIMAB 44 47% 6% 69 Search BASILIXIMAB Search BASILIXIMAB
2 THYMOGLOBULIN 36 47% 5% 56 Search THYMOGLOBULIN Search THYMOGLOBULIN
3 DACLIZUMAB 19 32% 4% 49 Search DACLIZUMAB Search DACLIZUMAB
4 ALEMTUZUMAB 13 14% 7% 82 Search ALEMTUZUMAB Search ALEMTUZUMAB
5 CAMPATH 1H 12 29% 3% 36 Search CAMPATH+1H Search CAMPATH+1H
6 ANTI THYMOCYTE GLOBULIN 10 16% 5% 56 Search ANTI+THYMOCYTE+GLOBULIN Search ANTI+THYMOCYTE+GLOBULIN
7 INDUCTION THERAPY 8 16% 4% 50 Search INDUCTION+THERAPY Search INDUCTION+THERAPY
8 RABBIT ANTITHYMOCYTE GLOBULIN 8 45% 1% 14 Search RABBIT+ANTITHYMOCYTE+GLOBULIN Search RABBIT+ANTITHYMOCYTE+GLOBULIN
9 SIMULECT 7 67% 1% 6 Search SIMULECT Search SIMULECT
10 ANTI IL 2 RECEPTOR 6 80% 0% 4 Search ANTI+IL+2+RECEPTOR Search ANTI+IL+2+RECEPTOR

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 BASILIXIMAB 54 44% 8% 94
2 ACUTE CELLULAR REJECTION 46 30% 11% 127
3 THYMOGLOBULIN 31 42% 5% 56
4 BASILIXIMAB INDUCTION 28 64% 2% 28
5 RABBIT ANTITHYMOCYTE GLOBULIN 28 32% 6% 72
6 CAMPATH 1H INDUCTION 27 66% 2% 25
7 FREE MAINTENANCE IMMUNOTHERAPY 25 77% 2% 17
8 ANTI THYMOCYTE GLOBULIN 25 13% 16% 179
9 DOSE CYCLOSPORINE MONOTHERAPY 22 48% 3% 34
10 ANTILYMPHOCYTE 21 71% 2% 17

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond 2007 154 63 41%
Alemtuzumab Induction Therapy in Kidney Transplantation: A Systematic Review and Meta-Analysis 2012 23 34 59%
Selection of induction therapy in kidney transplantation 2013 5 84 82%
A Review of the Evidence for Use of Thymoglobulin Induction in Renal Transplantation 2010 14 14 100%
Basiliximab: efficacy and safety evaluation in kidney transplantation 2014 3 63 57%
Interleukin 2 receptor antagonists for kidney transplant recipients 2010 31 145 54%
Alemtuzumab (Campath-1H) in kidney transplantation 2008 49 35 60%
Infectious Complications of Antilymphocyte Therapies in Solid Organ Transplantation 2009 49 110 47%
Rabbit Antithymocyte Globulin (Thymoglobulin (R)) A Review of its Use in the Prevention and Treatment of Acute Renal Allograft Rejection 2009 31 58 66%
Thymoglobulin and Its Use in Renal Transplantation: A Review 2013 6 100 56%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 LILLIAN JEAN K LAN RENAL TRANSPLANT TRAN 2 67% 0.2% 2
2 PHARMACOECON TRANSPLANT 2 67% 0.2% 2
3 TRANSPLANTAT NEPHROL CLIN IMMUNOL 2 67% 0.2% 2
4 HILLMAN PEDIAT TRANSPLANTAT 2 19% 0.7% 8
5 GKT HOSP 1 50% 0.2% 2
6 IMMUNOL CLIN SCI 1 50% 0.2% 2
7 KLIN ALLGEMEIN VISZERAL TRANSPLANTAT MED 1 100% 0.2% 2
8 SERV NEPHROL HTA DIALYSE TRANSPLANTAT 1 100% 0.2% 2
9 ABT TRANSPLANTAT 1 40% 0.2% 2
10 CARDIOL TRANSPLANT 1 40% 0.2% 2

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000263069 OKT3//MUROMONAB CD3//ANTI OKT3 ANTIBODIES
2 0.0000244220 STEROID WITHDRAWAL//CORTICOSTEROID WITHDRAWAL//EARLY STEROID WITHDRAWAL
3 0.0000122926 IMMUKNOW//IMMUNE FUNCTION ASSAY//CYLEX IMMUKNOW ASSAY
4 0.0000108356 COSTIMULATION BLOCKADE//EMORY TRANSPLANT//MIXED CHIMERISM
5 0.0000105710 SIROLIMUS//EVEROLIMUS//PROLIFERATION SIGNAL INHIBITORS
6 0.0000089692 SUBCLINICAL REJECTION//PROTOCOL BIOPSY//ALBERTA TRANSPLANT PL GENOM
7 0.0000072067 FK 506//FUJISAWA AMER//FUJISAWA AMER INC
8 0.0000071805 SIMULTANEOUS LIVER KIDNEY TRANSPLANTATION//DUAL ORGAN TRANSPLANTATION//COMBINED TRANSPLANTATION
9 0.0000066647 DELAYED GRAFT FUNCTION//EXPANDED CRITERIA DONORS//EXPANDED CRITERIA DONOR
10 0.0000061462 MYCOPHENOLIC ACID//MYCOPHENOLIC ACID GLUCURONIDE//MYCOPHENOLATE MOFETIL